Unlocking The Potential Of Your Sterile Injectables With Exact SI-ence

The pathway from early clinical phases to commercial is not straightforward, particularly for complex sterile injectable products. Time is life, and with patients waiting for life-changing medicines - the need for a clear path to market becomes even more important.

By fostering an extensive range of manufacturing capabilities and decades of experience, our experts can anticipate and prepare for potential roadblocks on the way. The implementation of robust processes, incorporating operational excellence and including protocols for data sharing can result in a simpler and more streamlined pathway to deliver high-quality therapeutics to patients.

In this webinar, our global Pfizer SI scientists and manufacturing experts explore key aspects of the sterile injectable journey including:

• Factors to consider during development and tech transfer stages of your sterile injectable project.
• The importance of having a range of specialized capabilities, from complex drug substances, like ADCs, to final fill finish to keep pace with the rapidly evolving market.
• The need for experience to proactively identify and prepare for the risks ahead.
• Strategies that can be applied to simplify the journey as the project scales.
• A Q&A session with our global Pfizer SI experts.

Click below to view the webinar!